BIO-RAD LABORATORIES-A (BIO) Institutional Ownership Changes & 13F Activity
BIO-RAD LABORATORIES-A (BIO). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Longleaf Partners, First Eagle U.S. Value, Ariel Appreciation Fund, Parnassus Endeavor Fund, and Sequoia Financial Advisors.
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q2 2024 | Ariel Appreciation Fund | Buy | 39,095 | 104,187 | $28,454,512 |
| Q2 2024 | Longleaf Partners | Sell | -18,946 | 325,013 | $88,764,300 |
| Q2 2024 | Meritage Group | Buy | 424 | 1,180 | $322,270 |
| Q1 2024 | Ariel Appreciation Fund | Buy | 60,615 | 65,092 | $22,513,370 |
| Q1 2024 | Longleaf Partners | Sell | -20,099 | 343,959 | $118,965,100 |
| Q1 2024 | First Eagle U.S. Value | Buy | 1,485 | 1,964 | $679,289 |
| Q1 2024 | Meritage Group | Sell | -61 | 756 | $261 |
| Q4 2023 | Longleaf Partners | Buy | 37,956 | 364,058 | $117,550,687 |
| Q4 2023 | Parnassus Endeavor Fund | Buy | 16,999 | 237,790 | $76,780,013 |
| Q4 2023 | Meritage Group | Buy | 64 | 817 | $264 |
| Q4 2023 | Ariel Appreciation Fund | Sell | -52 | 4,477 | $1,445,579 |
| Q4 2023 | Sequoia Financial Advisors | Sell | -25 | 831 | $268,322 |
| Q4 2023 | First Eagle U.S. Value | Buy | 21 | 479 | $154,664 |
| Q3 2023 | Parnassus Endeavor Fund | Buy | 220,791 | 220,791 | $79,142,534 |
| Q3 2023 | Longleaf Partners | Buy | 583 | 326,102 | $116,891,261 |
| Q3 2023 | First Eagle U.S. Value | Buy | 267 | 458 | $164,170 |
| Q3 2023 | Ariel Appreciation Fund | Buy | 136 | 4,529 | $1,623,420 |
| Q2 2023 | Longleaf Partners | Buy | 325,519 | 325,519 | $123,410,764 |
| Q2 2023 | Renaissance Technologies LLC | Sell | -37,100 | 1,100 | $417 |
| Q2 2023 | Ariel Appreciation Fund | Sell | -27,404 | 4,393 | $1,665,474 |
| Q2 2023 | Sequoia Financial Advisors | Buy | 856 | 856 | $324,527 |
| Q2 2023 | Meritage Group | Buy | 284 | 753 | $285 |
| Q2 2023 | First Eagle U.S. Value | Buy | 191 | 191 | $72,412 |
| Q1 2023 | Renaissance Technologies LLC | Sell | -63,943 | 38,200 | $18,299 |
| Q1 2023 | Ariel Appreciation Fund | Sell | -99 | 31,797 | $15,231,398 |
| Q4 2022 | Renaissance Technologies LLC | Buy | 39,443 | 102,143 | $42,950 |
| Q4 2022 | Ariel Appreciation Fund | Sell | -34,769 | 31,896 | $13,411,948 |
| Q3 2022 | Renaissance Technologies LLC | Sell | -91,800 | 62,700 | $26,155 |
| Q3 2022 | Ariel Appreciation Fund | Buy | 2,762 | 66,665 | $27,808 |
| Q2 2022 | Renaissance Technologies LLC | Sell | -33,300 | 154,500 | $76,478 |
Frequently asked questions about BIO activity
Which institutional owners are buying BIO?
Institutional owners buying BIO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BIO activity?
"Buy" means an investor increased their reported position in BIO compared to the prior reporting period. This reflects growing exposure to BIO-RAD LABORATORIES-A (BIO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BIO increasing?
Institutional interest in BIO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related BIO Institutional Insights
- BIO Institutional Ownership Overview
- BIO Institutional Ownership & Insiders Activity
- BIO Institutional Ownership & 13F Activity
- BIO Top Institutional Shareholders
- BIO Institutional Buying Activity
- BIO Institutional Selling Activity
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BIO Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings